GKOS - GLAUKOS Corp

115.37
-2.380   -2.063%

Share volume: 297,597
Last Updated: 03-04-2026
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies: -0.01%

PREVIOUS CLOSE
CHG
CHG%
$117.75
-2.38
-0.02%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
29%
Profitability 6%
Dept financing 30%
Liquidity 61%
Performance 44%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-4.75%
1 Month
1.63%
3 Months
6.32%
6 Months
22.81%
1 Year
2.90%
2 Year
36.84%
Key data
Stock price
$115.37
P/E Ratio 
0.00
DAY RANGE
$114.84 - $117.74
EPS 
-$3.28
52 WEEK RANGE
$73.16 - $130.23
52 WEEK CHANGE
$11.79
MARKET CAP 
6.485 B
YIELD 
N/A
SHARES OUTSTANDING 
58.079 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
07-30-2025
BETA 
0.60
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$664,326
AVERAGE 30 VOLUME 
$779,603
Company detail
CEO: Thomas W. Burns
Region: US
Website: glaukos.com
Employees: 780
IPO year: 2015
Issue type: Common Stock
Market: NYSE
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

Glaukos Corporation focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. The company markets its products through direct sales organization, as well as through distributors in the United States and internationally.

Recent news